Bio Protech Inc. (XKON:199290)
South Korea · Delayed Price · Currency is KRW 485.00
-14.00 (-2.81%)
At close: Aug 20, 2025, 3:30 PM KST
Bio Protech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2007 - 2010 |
|---|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2007 - 2010 |
Operating Revenue | 20,579 | 18,609 | 18,055 | 18,007 | 16,863 | Upgrade |
Other Revenue | - | - | - | -0 | - | Upgrade |
| 20,579 | 18,609 | 18,055 | 18,007 | 16,863 | Upgrade | |
Revenue Growth (YoY) | 10.59% | 3.07% | 0.27% | 6.78% | 2.22% | Upgrade |
Cost of Revenue | 16,441 | 15,084 | 15,322 | 12,875 | 13,186 | Upgrade |
Gross Profit | 4,137 | 3,525 | 2,733 | 5,132 | 3,677 | Upgrade |
Selling, General & Admin | 2,652 | 2,465 | 2,784 | 2,717 | 2,407 | Upgrade |
Research & Development | 11.5 | 26.48 | 211.2 | 270.14 | 18.85 | Upgrade |
Other Operating Expenses | -443.84 | -496.22 | -382.68 | -212.71 | -421.19 | Upgrade |
Operating Expenses | 2,866 | 2,628 | 3,316 | 3,059 | 2,417 | Upgrade |
Operating Income | 1,271 | 896.05 | -582.94 | 2,074 | 1,260 | Upgrade |
Interest Expense | -855.59 | -871.72 | -729.37 | -659.27 | -531.32 | Upgrade |
Interest & Investment Income | 16.76 | 12.47 | 10.86 | 15.46 | 17.29 | Upgrade |
Currency Exchange Gain (Loss) | 233.55 | 157.15 | -134.09 | -235.12 | -37.64 | Upgrade |
Other Non Operating Income (Expenses) | -23.09 | -120.42 | 28.14 | 6.35 | 42.1 | Upgrade |
EBT Excluding Unusual Items | 642.45 | 73.54 | -1,407 | 1,201 | 750.04 | Upgrade |
Gain (Loss) on Sale of Investments | -90 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.09 | 70.05 | 1.12 | - | 0.36 | Upgrade |
Pretax Income | 552.54 | 143.59 | -1,406 | 1,201 | 750.4 | Upgrade |
Income Tax Expense | - | - | 13.07 | 80.78 | 16.25 | Upgrade |
Net Income | 552.54 | 143.59 | -1,419 | 1,120 | 734.16 | Upgrade |
Net Income to Common | 552.54 | 143.59 | -1,419 | 1,120 | 734.16 | Upgrade |
Net Income Growth | 284.82% | - | - | 52.58% | 0.90% | Upgrade |
Shares Outstanding (Basic) | 3 | 4 | 2 | 2 | 2 | Upgrade |
Shares Outstanding (Diluted) | 3 | 4 | 2 | 4 | 3 | Upgrade |
Shares Change (YoY) | -22.65% | 131.41% | -58.73% | 31.59% | 0.11% | Upgrade |
EPS (Basic) | 199.00 | 40.00 | -915.00 | 579.00 | 380.00 | Upgrade |
EPS (Diluted) | 199.00 | 40.00 | -915.00 | 298.00 | 257.00 | Upgrade |
EPS Growth | 397.50% | - | - | 15.95% | 0.78% | Upgrade |
Free Cash Flow | -788.2 | -1,944 | -1,161 | -2,096 | -1,746 | Upgrade |
Free Cash Flow Per Share | -283.88 | -541.56 | -748.44 | -557.49 | -611.21 | Upgrade |
Gross Margin | 20.11% | 18.94% | 15.14% | 28.50% | 21.81% | Upgrade |
Operating Margin | 6.17% | 4.81% | -3.23% | 11.52% | 7.47% | Upgrade |
Profit Margin | 2.69% | 0.77% | -7.86% | 6.22% | 4.35% | Upgrade |
Free Cash Flow Margin | -3.83% | -10.45% | -6.43% | -11.64% | -10.35% | Upgrade |
EBITDA | 2,455 | 1,936 | 821.03 | 2,843 | 1,885 | Upgrade |
EBITDA Margin | 11.93% | 10.41% | 4.55% | 15.78% | 11.18% | Upgrade |
D&A For EBITDA | 1,184 | 1,040 | 1,404 | 769 | 625.49 | Upgrade |
EBIT | 1,271 | 896.05 | -582.94 | 2,074 | 1,260 | Upgrade |
EBIT Margin | 6.17% | 4.81% | -3.23% | 11.52% | 7.47% | Upgrade |
Effective Tax Rate | - | - | - | 6.73% | 2.17% | Upgrade |
Advertising Expenses | 117.9 | 60.69 | 30.12 | 51.02 | 38.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.